Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.

NCT01268215 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Bronchopulmonary Dysplasia

Interventions

DRUG: Infasurf
DRUG: Pulmicort
OTHER: Sham

Sponsor

East Carolina University